FS KKR Capital Corp (FSK) is a business development company, or BDC, that provides primarily senior secured loans to private U.S. middle-market companies. Because BDCs generate income rather than traditional sales growth, analysts typically value them on price-to-net asset value (NAV) and dividend coverage rather than on earnings per share.
Seven current, attributable analyst targets were reviewed for this analysis. The individual targets are: Wells Fargo $10 (Underweight, September 2026), J.P. Morgan $11 (Neutral, August 2026), KBW $11 (Market Perform, August 2026), Truist Financial $12 (Hold, August 2026), Lucid Capital $12 (Neutral, August 2026), RBC Capital $13 (Sector Perform, August 2026), and Oppenheimer $13 (Hold, August 2026). The simple average of these figures is about $11.71, which rounds to a central target of $12.
The low-to-high range of $10 to $13 is unusually wide in percentage terms, spanning from slightly below the current price to roughly 28% above it. This spread reflects a genuine split: some analysts see the dividend as sustainable and the shares as cheap relative to a book value of about $18.30 per share, while others warn that falling net investment income and dividend cuts justify a discount. The overall rating posture is a cautious "Hold" or "Reduce," with no Buy ratings among recent updates.
Shares closed at $10.13 on October 20, 2026, near the 52-week low of $9.72 and far below the 52-week high of $16.31. Reaching $12 would require an advance of roughly 18.5%, a substantial move given the stock's recent downtrend and its roughly 0.60 price-to-book ratio.
The path toward $12 would most plausibly require two things: evidence that the dividend has stabilized, and a re-rating of the shares toward a narrower discount to NAV. The stock currently trades well below its reported book value per share of about $18.30, which gives valuation-minded bulls a clear argument. However, a BDC's book value only matters if the underlying loan portfolio holds up and the distribution remains covered by net investment income, or NII, which has been under pressure.
Several factors could support a recovery. Second-quarter 2026 results beat expectations, with NII of $0.44 per share versus a roughly $0.42 consensus and revenue of $290 million, while investments on non-accrual status improved to 3.8% of the portfolio from 4.2% the prior quarter. The company has also been repurchasing shares, which management has framed as a signal that the stock trades below intrinsic value, and it maintains a quarterly distribution alongside a sizable yield near 20%.
Broader private-credit demand and a large, diversified senior secured loan book provide an earnings base. If credit quality keeps improving and NII stabilizes, the case for a narrower NAV discount — and a move toward the $12 area — would strengthen.
The risks are significant. Trailing-twelve-month net income is deeply negative, and the base dividend has already been reduced. Wells Fargo downgraded the shares to Underweight in late September 2026, and a series of firms cut price targets sharply through 2026 as credit impairments weighed on NAV. A high dividend yield can itself be a warning sign when earnings do not fully cover the payout.
If credit deterioration resumes, non-accruals rise, or interest-rate conditions compress loan yields, analysts could cut targets further and the discount to NAV could persist or widen. A sustained move toward $12 would likely be blocked if NII does not stabilize and the distribution is reduced again.
From a technical standpoint, the stock is below both its 50-day moving average near $11.59 and its 200-day moving average near $11.52, indicating a persistent downtrend. The 52-week low of $9.72 and the round-number $10 level act as support, while the $11.50-to-$12 zone — which contains the moving averages and several analyst targets — represents a meaningful resistance area that price would need to clear.
Analyst price targets generally reflect a research horizon of roughly 12 months, though firms do not always state this explicitly and horizons can differ. The next confirmed earnings date is November 5, 2026, and it is the most important near-term catalyst. Investors should watch reported NII per share, the non-accrual rate, changes to NAV, any dividend declaration, and whether the company continues its buyback program. Further analyst rating or target changes will also be telling, given the recent wave of downgrades.
For traders who want to track changing conditions on FSK and thousands of other securities, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor stocks and ETFs and generate Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening allows. Explore the signals to see how they apply to your watchlist.
The $12 target is a reasonable reading of the current analyst landscape — the rounded average of seven verified targets spanning $10 to $13 — but it is not a consensus forecast and not a guarantee. At $10.13, reaching it would require a substantial 18.5% advance that hinges on stabilizing NII, a durable dividend, and continued credit improvement. The shares trade at a steep discount to NAV and carry an attractive yield, but negative net income, recent downgrades, and prior dividend cuts are meaningful obstacles. The November earnings report and any change to the distribution will be the clearest signals of whether that path is opening or closing.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, FSK has been closely correlated with NMFC. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if FSK jumps, then NMFC could also see price increases.
| Ticker / NAME | Correlation To FSK | 1D Price Change % | ||
|---|---|---|---|---|
| FSK | 100% | -0.49% | ||
| NMFC - FSK | 66% Closely correlated | -0.91% | ||
| ARCC - FSK | 66% Loosely correlated | -0.59% | ||
| BBDC - FSK | 62% Loosely correlated | -0.84% | ||
| OBDC - FSK | 62% Loosely correlated | -0.40% | ||
| BCSF - FSK | 61% Loosely correlated | -0.69% | ||
More | ||||